Lilly, Novo bet on amylin obesity drugs after GLP-1s
Photo illustration of a group of weight loss medications on a white background. Ucg | Universal Images Group | Getty
Read More
Latest:
- These AI Experts Want to Do High-Stakes Research Out in the Open
- Virgin River’s Ben Hollingsworth Wants Jana Kramer to Join
- Kalen DeBoer Is Unreal vs. Top-25 Teams On The Road — But Ryan Day Isn’t Far Behind
- England fast bowler Carse charged over nightclub incident by Cricket Regulator
- Ek junoon hota hai: After a long wait, Lone Nasir has his moment of reckoning
Friday, October 2, 2026
iShares Biotechnology ETF